#begin document (nw/wsj/12/wsj_1242); part 000
nw/wsj/12/wsj_1242   0    0             Bausch    NNP    (TOP(S(NP*            -    -   -   -   (ORG*   (ARG0*        *        *      (4
nw/wsj/12/wsj_1242   0    1                  &     CC             *            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0    2               Lomb    NNP             *            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0    3               Inc.    NNP             *)           -    -   -   -       *)       *)       *        *       4)
nw/wsj/12/wsj_1242   0    4               said    VBD          (VP*           say  01   1   -       *      (V*)       *        *       -
nw/wsj/12/wsj_1242   0    5                its   PRP$   (SBAR(S(NP*            -    -   -   -       *   (ARG1*   (ARG0*   (ARG0*      (4)
nw/wsj/12/wsj_1242   0    6    pharmaceuticals    NNS             *            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0    7         subsidiary     NN             *)   subsidiary   -   2   -       *        *        *)       *)      -
nw/wsj/12/wsj_1242   0    8             agreed    VBD          (VP*         agree  01   3   -       *        *      (V*)       *      (0)
nw/wsj/12/wsj_1242   0    9                 to     TO        (S(VP*            -    -   -   -       *        *   (ARG1*        *       -
nw/wsj/12/wsj_1242   0   10             supply     VB          (VP*        supply  01   1   -       *        *        *      (V*)      -
nw/wsj/12/wsj_1242   0   11           collagen     NN       (NP(NP*            -    -   -   -       *        *        *   (ARG1*      (2
nw/wsj/12/wsj_1242   0   12            corneal     JJ             *            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   13            shields    NNS             *)           -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   14                for     IN          (PP*            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   15             animal     NN          (NP*            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   16                eye     NN             *           eye   -   1   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   17            surgery     NN           *)))           -    -   -   -       *        *        *        *)      2)
nw/wsj/12/wsj_1242   0   18                 to     IN          (PP*            -    -   -   -       *        *        *   (ARG2*       -
nw/wsj/12/wsj_1242   0   19                  a     DT       (NP(NP*            -    -   -   -       *        *        *        *      (3
nw/wsj/12/wsj_1242   0   20               unit     NN             *)         unit   -   2   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   21                 of     IN          (PP*            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   22      International    NNP          (NP*            -    -   -   -   (ORG*        *        *        *      (1
nw/wsj/12/wsj_1242   0   23           Minerals   NNPS             *            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   24                  &     CC             *            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   25           Chemical    NNP             *            -    -   -   -       *        *        *        *       -
nw/wsj/12/wsj_1242   0   26               Corp    NNP   *)))))))))))           -    -   -   -       *)       *)       *)       *)   3)|1)
nw/wsj/12/wsj_1242   0   27                  .      .            *))           -    -   -   -       *        *        *        *       -

nw/wsj/12/wsj_1242   0   0        Terms   NNS   (TOP(S(NP*)       term   -   3   -   *        (ARG1*)  -
nw/wsj/12/wsj_1242   0   1         were   VBD         (VP*          -    -   -   -   *             *   -
nw/wsj/12/wsj_1242   0   2          n't    RB            *          -    -   -   -   *    (ARGM-NEG*)  -
nw/wsj/12/wsj_1242   0   3    disclosed   VBN        (VP*))   disclose  01   1   -   *           (V*)  -
nw/wsj/12/wsj_1242   0   4            .     .           *))         -    -   -   -   *             *   -

nw/wsj/12/wsj_1242   0    0              The     DT   (TOP(S(NP*           -    -   -   -           *   (ARG0*            *        *    (0
nw/wsj/12/wsj_1242   0    1        agreement     NN            *)   agreement   -   1   -           *        *)           *        *     0)
nw/wsj/12/wsj_1242   0    2            marks    VBZ         (VP*         mark  01   3   -           *      (V*)           *        *     -
nw/wsj/12/wsj_1242   0    3           Bausch    NNP   (NP(NP(NP*           -    -   -   -       (ORG*   (ARG1*       (ARG0*        *    (4
nw/wsj/12/wsj_1242   0    4                &     CC            *           -    -   -   -           *        *            *        *     -
nw/wsj/12/wsj_1242   0    5             Lomb    NNP            *           -    -   -   -           *        *            *        *     -
nw/wsj/12/wsj_1242   0    6               's    POS            *)          -    -   -   -           *)       *            *        *     4)
nw/wsj/12/wsj_1242   0    7            first     JJ            *           -    -   -   -    (ORDINAL)       *            *        *     -
nw/wsj/12/wsj_1242   0    8          venture     NN            *)     venture   -   3   -           *        *            *)       *     -
nw/wsj/12/wsj_1242   0    9          selling    VBG         (VP*         sell  01   1   -           *        *          (V*)       *     -
nw/wsj/12/wsj_1242   0   10              its   PRP$         (NP*           -    -   -   -           *        *       (ARG1*        *    (4)
nw/wsj/12/wsj_1242   0   11              eye     NN        (NML*          eye   -   1   -           *        *            *        *     -
nw/wsj/12/wsj_1242   0   12             care     NN            *)        care   -   1   -           *        *            *        *     -
nw/wsj/12/wsj_1242   0   13         products    NNS            *)     product   -   1   -           *        *            *)       *     -
nw/wsj/12/wsj_1242   0   14              for     IN         (PP*           -    -   -   -           *        *   (ARGM-PNC*        *     -
nw/wsj/12/wsj_1242   0   15              use     NN      (NP(NP*)         use  01   2   -           *        *            *      (V*)    -
nw/wsj/12/wsj_1242   0   16               by     IN         (PP*           -    -   -   -           *        *            *   (ARG0*     -
nw/wsj/12/wsj_1242   0   17    veterinarians    NNS   (NP*)))))))          -    -   -   -           *        *)           *)       *)    -
nw/wsj/12/wsj_1242   0   18                .      .           *))          -    -   -   -           *        *            *        *     -

nw/wsj/12/wsj_1242   0    0         The    DT  (TOP(S(NP*       -    -   -   -   *   (ARG0*   (ARG0*   (2
nw/wsj/12/wsj_1242   0    1    collagen    NN           *       -    -   -   -   *        *        *    -
nw/wsj/12/wsj_1242   0    2     corneal    JJ           *       -    -   -   -   *        *        *    -
nw/wsj/12/wsj_1242   0    3      shield    NN           *)      -    -   -   -   *        *)       *)   2)
nw/wsj/12/wsj_1242   0    4       helps   VBZ        (VP*     help  01   1   -   *      (V*)       *    -
nw/wsj/12/wsj_1242   0    5       speed    VB        (VP*    speed  01   2   -   *   (ARG1*      (V*)   -
nw/wsj/12/wsj_1242   0    6     healing    NN     (NP(NP*)      -    -   -   -   *        *   (ARG1*    -
nw/wsj/12/wsj_1242   0    7          of    IN        (PP*       -    -   -   -   *        *        *    -
nw/wsj/12/wsj_1242   0    8         the    DT        (NP*       -    -   -   -   *        *        *    -
nw/wsj/12/wsj_1242   0    9      cornea    NN          *))      -    -   -   -   *        *        *    -
nw/wsj/12/wsj_1242   0   10       after    IN        (PP*       -    -   -   -   *        *        *    -
nw/wsj/12/wsj_1242   0   11         eye    NN        (NP*      eye   -   1   -   *        *        *    -
nw/wsj/12/wsj_1242   0   12     surgery    NN       *)))))      -    -   -   -   *        *)       *)   -
nw/wsj/12/wsj_1242   0   13           .     .          *))      -    -   -   -   *        *        *    -

nw/wsj/12/wsj_1242   0    0              The     DT  (TOP(S(NP*            -    -   -   -       *        (ARG1*      (2
nw/wsj/12/wsj_1242   0    1          product     NN           *)      product   -   1   -       *             *)      2)
nw/wsj/12/wsj_1242   0    2             will     MD        (VP*            -    -   -   -       *    (ARGM-MOD*)      -
nw/wsj/12/wsj_1242   0    3               be     VB        (VP*            -    -   -   -       *             *       -
nw/wsj/12/wsj_1242   0    4      distributed    VBN        (VP*    distribute  01   1   -       *           (V*)      -
nw/wsj/12/wsj_1242   0    5               by     IN        (PP*            -    -   -   -       *        (ARG0*       -
nw/wsj/12/wsj_1242   0    6           Pitman    NNP     (NP(NP*            -    -   -   -   (ORG*             *      (3
nw/wsj/12/wsj_1242   0    7               -    HYPH           *            -    -   -   -       *             *       -
nw/wsj/12/wsj_1242   0    8            Moore    NNP           *            -    -   -   -       *             *       -
nw/wsj/12/wsj_1242   0    9             Inc.    NNP           *)           -    -   -   -       *)            *       -
nw/wsj/12/wsj_1242   0   10                ,      ,           *            -    -   -   -       *             *       -
nw/wsj/12/wsj_1242   0   11                a     DT     (NP(NP*            -    -   -   -       *             *       -
nw/wsj/12/wsj_1242   0   12       subsidiary     NN           *)   subsidiary   -   2   -       *             *       -
nw/wsj/12/wsj_1242   0   13               of     IN        (PP*            -    -   -   -       *             *       -
nw/wsj/12/wsj_1242   0   14    International    NNP        (NP*            -    -   -   -   (ORG*             *      (1
nw/wsj/12/wsj_1242   0   15         Minerals   NNPS    *))))))))           -    -   -   -       *)            *)   3)|1)
nw/wsj/12/wsj_1242   0   16                .      .          *))           -    -   -   -       *             *       -

#end document
